Literature DB >> 27012448

Successful eradication of Helicobacter pylori infection with vonoprazan-based triple therapy after failure of PPI-based triple therapy.

Kousaku Kawashima1, Shunji Ishihara2, Yoshikazu Kinoshita2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27012448     DOI： 10.1016/j.dld.2016.02.021

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN： 1590-8658            Impact factor:   4.088


× No keyword cloud information.
  3 in total

Review 1.  Vonoprazan: A Novel and Potent Alternative in the Treatment of Acid-Related Diseases.

Authors:  Xiaoxiao Yang; Yueyue Li; Yiyuan Sun; Mingming Zhang; Chuanguo Guo; Iqtida Ahmed Mirza; Yan-Qing Li
Journal:  Dig Dis Sci       Date:  2017-12-27       Impact factor: 3.199

Review 2.  Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases.

Authors:  Tadayuki Oshima; Hiroto Miwa
Journal:  J Neurogastroenterol Motil       Date:  2018-07-30       Impact factor: 4.924

3.  Evaluation of safety and pharmacokinetics of bismuth-containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication.

Authors:  Ki Young Huh; Hyewon Chung; Yu Kyong Kim; SeungHwan Lee; Siddharth Bhatia; Yohei Takanami; Ryou Nakaya; Kyung-Sang Yu
Journal:  Br J Clin Pharmacol       Date:  2021-06-26       Impact factor: 3.716
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.